39 results
Page 2 of 2
6-K
EX-99.1
fksrai7qbv7upump9 o3
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-4.1
5og4rlwjkmoacxjp
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
6-K
EX-1.1
4q9wv hhzs7r3vpt
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
F-1/A
EX-1.1
ft0 55j3bmqmuw
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
EX-4.4
aey4jqm
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
6-K
EX-99.1
w3mcvnm
23 Jun 20
Annual and Special General Meeting of Shareholders
9:06am
424B4
zu0 s04f4goe4
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
g6vehusoexzcpxzu
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
a8w1k9
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
esfljym3ihzr6232
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
t2b60gafx
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
6-K
EX-99.1
c6wy8o 0gcwpvftw4
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
6-K
EX-99.1
319f5
6 Dec 18
Therapix Biosciences Reports Third
6:18am
6-K
EX-10.3
pgz0az
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
6-K
EX-99.1
m585lemw 75aodnyln
6 Jun 18
Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update
4:55pm
20-F
td39gg43m2pzbyz7fsdn
1 May 17
Annual report (foreign)
12:00am